Polycystic Ovary Syndrome (PCOS) is a very common disease in gynecological endocrine clinics. Its clinical manifestations are heterogeneous, which seriously affects the quality of life of women. Therefore, this article proposes a study on the relationship between ovarian and systemic immune cell homeostasis and autophagy levels in patients with polycystic ovary syndrome during pregnancy, aiming to explore the relationship between cell homeostasis and autophagy in PCOS patients, and help patients get rid of them as soon as possible disease. This article mainly adopts various methods such as literature data method and experimental analysis method to gain an in-depth understanding of the clinical manifestations, pathological characteristics and related treatment research of PCOS, as well as auxiliary diagnosis methods under intelligent medical treatment. On the basis of the above theories, design Experiments related to the imbalance of cell homeostasis and autophagy level in PCOS patients. Through the serum test and glucose tolerance test of the patients, and the use of homeostasis model for evaluation, the biochemical characteristics, insulin resistance index, protein expression level and other related factors of the patients were analyzed. The protein expression of follicular granule cells in the PCOS group was higher than that in the control group (P<0.05), which was statistically different.

Yingjie Tang and Yingzheng Pan. Relationship between Homeostasis of Ovarian and Systemic Immune Cells in Patients with Polycystic Ovary Syndrome and Autophagy Levels during Pregnancy. International Journal of Frontiers in Medicine (2021), Vol. 3, Issue 5: 7-20. https://doi.org/10.25236/IJFM.2021.030502.

[1] Wu X K, Stener-Victorin E, Kuang H Y, et al. Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial [J]. JAMA The Journal of the American Medical Association, 2017, 317(24):2502-2514.

[2] Yin Z, Pascual C, D Klionsky. Autophagy: machinery and regulation [J]. Microbial Cell, 2016, 3(12):588-596.

[3] Pedros C, Duguet F, Saoudi A, et al. Disrupted regulatory T cell homeostasis in inflammatory bowel diseases [J]. World J Gastroenterol, 2016(3):974-995.

[4] Polak K, Czyzyk A, Simoncini T, et al. New markers of insulin resistance in polycystic ovary syndrome [J]. Journal of Endocrinological Investigation, 2017, 40(1):1-8.

[5] Xue Y, Xu P, Xue K, et al. Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis [J]. Archives of Gynecology & Obstetrics, 2017, 295(2):1-10.

[6] None. ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome [J]. Obstet Gynecol, 2018, 100(6):e157-e171.

[7] Steffen Diegmüller, Richard Spörri. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial [J]. Hormone & Metabolic Research, 2017, 49(07):493-498.

[8] Hanstein B, Beckmann M W, Bender H G. Effects of Quercetin on Adiponectin-Mediated Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized Placebo-Controlled Double-Blind Clinical Trial [J]. Hormone & Metabolic Research, 2017, 49(02):115-121.

[9] Tang Y L, Yu J, Zeng Z G, et al. Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis [J]. Gynecological Endocrinology, 2017, 33(3):1-6.

[10] Cardozo L Y, Romero D G, Reckelhoff J F. Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens [J]. Physiology, 2017, 32(5):357-366.

[11] Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters[J]. Journal of Endocrinological Investigation, 2017, 40(5):487-497.

[12]  Palomba S, Daolio J, Sala G L. Oocyte Competence in Women with Polycystic Ovary Syndrome [J]. Trends in Endocrinology & Metabolism, 2017, 28(3):186-198.

[13]  Kim J Y ,  Tfayli H ,  Michaliszyn S F , et al. Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome[J]. Journal of Adolescent Health Official Publication of the Society for Adolescent Medicine, 2017, 60(3):333-339.

[14]  Reis G, Gontijo N A, Rodrigues K F, et al. Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review [J]. Journal of Obstetrics & Gynaecology Research, 2017, 43(3):436-446.

[15]  Kim J Y, Tfayli H, Michaliszyn S F, et al. Impaired Lipolysis, Diminished Fat Oxidation and Metabolic Inflexibility in Obese Girls with Polycystic Ovary Syndrome [J]. Journal of Clinical Endocrinology & Metabolism, 2017, 103(2):546-554.

[16]  Kochergin I A, Zakharova M N. The role of autophagy in neurodegenerative diseases [J]. Neurochemical Journal, 2016, 10(1):7-18.

[17] Varshavsky, Alexander. The Ubiquitin System, Autophagy, and Regulated Protein Degradation [J]. Annual Review of Biochemistry, 2017, 86(1):123-128.

[18] Hong, Xin, Liu, et al. Resveratrol attenuated TNF-alpha-induced MMP-3 expression in human nucleus pulposus cells by activating autophagy via AMPK/SIRT1 signaling pathway[J]. Experimental Biology and Medicine: Journal of the Society for Experimental Biology and Medicine, 2016, 241(8):848-853.

[19] Sarparanta, Jaakko, Garcia-Macia, et al. Autophagy and Mitochondria in Obesity and Type 2 Diabetes [J]. Current Diabetes Reviews, 2017, 13(4):352-369.

[20]  Ju J S, Jeon S I, Park J Y, et al. Autophagy plays a role in skeletal muscle mitochondrial biogenesis in an endurance exercise-trained condition [J]. Journal of Physiological Sciences Jps, 2016, 66(5):417-430.

[21]  Zeissig S, Peuker K, Iyer S, et al. CD1d-Restricted pathways in hepatocytes control local natural killer T cell homeostasis and hepatic inflammation [J]. Proc Natl Acad Sci U S A, 2017, 114(39):10449-10454.

[22]  Degottardi M Q ,  Okoye A A ,  Vaidya M , et al. Effect of Anti–IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques[J]. Journal of Immunology, 2016, 197(4):1183-1198.

[23]  Cao W, Kayama H, Chen M L, et al. The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids [J]. Immunity, 2017, 47(6):1182-1196.

[24]  Galluzzi L, A López-Soto, Kumar S, et al. Caspases Connect Cell-Death Signaling to Organismal Homeostasis [J]. Immunity, 2016, 44(2):221-231.

[25] Elisabetta, Catalani, Davide, et al. Diabetic retinopathy: a matter of retinal ganglion cell homeostasis [J]. Neural Regeneration Research, 2020, v. 15(07):87-88.

[26]  Holt M P, Punkosdy G A, Glass D D, et al. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis [J]. Journal of Immunology, 2017, 198(4):1503-1511.